Table 1.
Ndiop | Dielmo | ||||||||||||||||
Quinine, | Chloroquine, | Fansidar, | ACT, | Quinine, | Chloroquine, | Fansidar, | ACT, | ||||||||||
Model | p | ||||||||||||||||
EIR | 4 | −141 | 292 | −433 | 874 | −143 | 296 | −94 | 198 | −227 | 463 | −398 | 804 | −134 | 277 | −121 | 252 |
Sp | 3 | −113 | 233 | −381 | 768 | −124 | 255 | −90 | 187 | −223 | 452 | −399 | 804 | −128 | 263 | −122 | 251 |
SpTR | 5 | −109 | 231 | −378 | 766 | −121 | 254 | −86 | 186 | −223 | 457 | −391 | 792 | −121 | 254 | −115 | 243 |
SpROT | 6 | −117 | 250 | −521 | 1055 | −119 | 254 | −87 | 192 | −222 | 458 | −392 | 797 | −121 | 257 | −115 | 246 |
For each drug period transmission was modeled by means of the entomological inoculation rate (EIR), only with splines (Sp) and with splines and anomalies of rain and temperature (SpTR and SpROT). The p-labeled column corresponds to the number of free parameters. The rest of the parameters were fixed at the maximum-likelihood estimated values listed in Tables S3 and S4. The second-order Akaike information criterion () is computed as with n the number of observations. The best fits are shown in boldface type. Overall the fit improves when temperature and rainfall anomalies are considered (SpTR model).